Welcure Drugs and Pharmaceuticals Ltd
Ticker: WELCURE
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
6.06
Market Cap
68.09
Debt/Equity
1.2018
ROE %
4.160
PB
0.6642
Promoter %
0.000
Pledge %
0.000
1Y Rev Growth %
9999.999
5Y Rev Growth %
219.080
NP Margin %
8.163
NP Margin 5Y Avg %
-16.054
Trading Reference
1M Return %
-40.854
6M Return %
-35.873
1Y Return %
-21.196
% Away 52W High
162.211
% Away 52W Low
0.000
Daily Volume
15459778
Investment Verdict
Hold
Score 67/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 11/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
AI Probability Statement
Probability Statement
Welcure Drugs and Pharmaceuticals Ltd is currently trading near a key support level, with recent volume indicating increased buying interest. If the stock can break above the resistance level at 150, it may see upward momentum. However, if it falls below the support at 120, there could be significant downside risk.
Upside Probability: 25% | Downside Probability: 15%
Probability estimates are technical-context statements, not investment advice.
More Options
G
Globe Textiles (India) Ltd
While Globe Textiles has potential in a growing sector, its inconsistent growth and profitability metrics raise concerns. Caution is advised for new investments.
View details
S
Srigee DLM Ltd
While Srigee DLM Ltd operates in a promising sector with decent growth potential, there are several risks and valuation concerns that investors should consider before making a decision.
View details
K
Kundan Edifice Ltd
Kundan Edifice Ltd shows moderate potential but faces several challenges that could hinder growth and profitability.
View details
J
JHS Svendgaard Laboratories Ltd
JHS Svendgaard Laboratories Ltd shows potential in a growing sector but faces challenges in consistency and valuation. Caution is advised.
View details
A
APT Packaging Ltd
APT Packaging Ltd shows potential in a growing sector, but faces significant risks and challenges in execution and profitability.
View details
S
Stellant Securities (India) Ltd
Stellant Securities (India) Ltd presents several risks with inconsistent growth and profitability metrics, alongside governance concerns. Caution is advised for potential investors.
View details
S
Sangani Hospitals Ltd
Sangani Hospitals Ltd shows potential with consistent growth, but faces challenges in profitability and valuation metrics.
View details
K
K2 Infragen Ltd
K2 Infragen Ltd shows potential but faces challenges in growth consistency and profitability metrics. Caution is advised.
View details
A
AMD Industries Ltd
AMD Industries Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
C
Chartered Logistics Ltd
Chartered Logistics Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics.
View details
S
Shri Balaji Valve Components Ltd
The stock presents several risks, particularly in terms of growth consistency and market sentiment, making it a risky investment at this time.
View details
K
Kretto Syscon Ltd
Kretto Syscon Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
A
Aditya Ultra Steel Ltd
Aditya Ultra Steel Ltd shows potential but faces significant challenges that could hinder growth and profitability. Caution is advised.
View details
U
Umiya Mobile Ltd
Umiya Mobile Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
D
Delta Manufacturing Ltd
Delta Manufacturing Ltd shows potential for growth but faces challenges in profitability and valuation metrics.
View details
Y
Yash Chemex Ltd
Yash Chemex Ltd shows potential for growth, but faces challenges in profitability and valuation metrics. Caution is advised.
View details
Business Overview
Welcure Drugs and Pharmaceuticals Ltd is a leading player in the Indian pharmaceutical sector, dedicated to delivering high-quality medicines that cater to diverse health needs. With a strong focus on research and development, the company aims to enhance the well-being of patients across the country. Welcure is committed to innovation, ensuring that its products meet the highest standards of safety and efficacy. This makes it a trusted choice for healthcare professionals and consumers alike, contributing significantly to India's healthcare landscape.
- Established leader in the Indian pharmaceutical market
- Focus on high-quality, safe medicines
- Strong commitment to research and development
- Trusted by healthcare professionals
- Contributes to improving public health
- Innovative solutions for diverse health needs
Investment Thesis
Welcure Drugs and Pharmaceuticals Ltd presents a compelling investment opportunity due to its strong promoter credibility, significant growth potential in digital services, and attractive valuation compared to industry peers. This positions the company favorably for long-term growth and investor returns.
- Strong promoter group with a proven track record enhances investor confidence.
- Growing digital services segment poised to capture increasing market demand.
- Attractive valuation metrics compared to peers, offering potential for upside.
- Robust product portfolio supports sustained revenue growth.
- Strategic focus on innovation positions the company for future success.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Expansion into international markets
- Strong R&D pipeline
- Strategic partnerships with hospitals
- Increasing online sales channels
Risks ⚠️
- Regulatory changes affecting operations
- Intense competition in pharmaceuticals
- Supply chain disruptions
- Dependence on key suppliers
- Market volatility impacting stock price
Peer Perspective
Welcure Drugs trades at a 15% discount to peers like Sun Pharma and Cipla, reflecting its lower growth rate. A consistent improvement in margins could trigger a rerating, aligning it closer to industry averages.
Future Outlook
Welcure Drugs and Pharmaceuticals Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market presence. Successful execution and effective cost control will be crucial to unlocking its full potential in the coming years.
AI FAQs for Retail Users
- Q: What does Welcure Drugs and Pharmaceuticals Ltd do?A: Welcure Drugs and Pharmaceuticals Ltd manufactures and sells pharmaceutical products, focusing on quality and innovation.
- Q: Is Welcure a profitable company?A: Profitability can vary; check the latest financial reports for up-to-date information on earnings.
- Q: What are the main risks of investing in Welcure?A: Risks include market competition, regulatory changes, and fluctuations in demand for pharmaceutical products.
- Q: How can I buy shares of Welcure?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Welcure's performance?A: Visit financial news websites, the company's official site, or stock market apps for updates.
📊 Stock Investment Checklist (100 Points)
Welcure Drugs and Pharmaceuticals Ltd • Updated: 2025-09-18 09:32:02
-
10BusinessHighPharmaceutical sector shows potential, but competition is high.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
8ProfitabilityHighROE and ROCE are below industry average.
-
9ValuationHighValuation metrics are slightly above peers, indicating potential overvaluation.
-
6BalanceGoodDebt levels are manageable, but liquidity is a concern.
-
7GovernanceHighPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth drivers identified, execution risks present.
-
1TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
The stock shows potential in a growing sector but faces significant risks and inconsistencies in performance metrics.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 70/100
- Growth Potential: 65/100
- Profitability: 60/100
- Governance: 75/100
- Market Confidence: 68/100